Evaluation of Upper Abdomen Imaging With Low Field MRI Scanner (0.4T)
NCT ID: NCT06049563
Last Updated: 2024-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2023-12-21
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study is conducted on 40 consecutive adults, not vulnerable, patients who are already scheduled for diagnostic imaging examinations on the upper abdominal organs with the reference device.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
T2 Weighted Imaging of the Liver With Fast Spin Echo MRI
NCT02186054
Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T
NCT00554073
Liver Fat and Iron Quantification MRI
NCT03162302
Comparing Magnetic Resonance Imaging/Spectroscopy Techniques
NCT00001219
Evaluation of 4D Magnetic Resonance Flow Sequence at Hepatic Level
NCT02821078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
a) compare the image quality of the upper abdominal organs obtained with 0.4 T systems and with 1.5 T systems; This will be assessed via a noninferiority study on image quality. The image quality will be assessed by two experienced radiologists (more than 5 years' experience) and a trainee radiologist (at least 2 years) via blinded independent readings of the diagnostic images acquired both on the low-field 0.4T MRI device and on reference device e.g. the high-end 1.5T MRI device
Secondary endpoints of this study are:
1. evaluate the accuracy of representation and measurement (diameters, volumes) of the gallbladder and bile and pancreatic ducts;
2. compare the exam comfort with 0.4 T systems and with 1.5 T systems by means of questionnaires on the exam comfort provided to the subjects
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Enrolled subjects
An additional MRI scan of the upper abdomen will be performed on all the subjects with the low-field 0.4 T MRI system.
Diagnostic MRI
MRI scan of the upper abdomen performed with the low-field 0.4T MRI system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic MRI
MRI scan of the upper abdomen performed with the low-field 0.4T MRI system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age :18 years old or higher
* the subject must be capable and willing to fulfill all study requirements
Exclusion Criteria
* poor cooperation
* claustrophobia (only for 1.5T MRI)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Esaote S.p.A.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierpaolo Palumbo, MD
Role: PRINCIPAL_INVESTIGATOR
U.O.C Radiologia II Universitaria, S. Salvatore Hospital, L'Aquila, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
U.O.C Radiologia II Universitaria, S. Salvatore Hospital,
L’Aquila, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wacker F, Branding G, Zimmer T, Faiss S, Wolf KJ. [MR cholangiopancreatography using an open low field system of 0.2 tesla: early clinical results compared with a high field system (1.5 tesla) and ERCP]. Rofo. 1997 Dec;167(6):579-84. doi: 10.1055/s-2007-1015586. German.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIP000001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.